Stock BTSG BRIGHTSPRING HEALTH SERVICES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus BrightSpring Health Services, Inc.

Equities

BTSG

US10950A1060

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
11.32 USD -0.96% Intraday chart for BrightSpring Health Services, Inc. -1.31% 0.00%
May. 22 BrightSpring Health Services Completes Three Acquisitions MT
May. 20 BrightSpring Health Services Says Onco360 Selected as Pharmacy Partner for Ojemda MT

Evolution of the average Target Price on BrightSpring Health Services, Inc.

Price target over the last 5 years

History of analyst recommendation changes

40755f211889af6f237691f.VhcHhNtsl8Hp5muPDkRcumFmc6FRc-oBWkud04MCS7k.HXQys5099qe9tS_QdBI9iFUPPO0jQJtzLXj75-JlOI1gUG7tmD_AoJi2Og~68300b34bf4b0cfc57eeb7d03e4af964

Analyst Recommendations on BrightSpring Health Services, Inc.

Wells Fargo Adjusts Price Target on BrightSpring Health Services to $16 From $15, Maintains Overweight Rating MT
Deutsche Bank Adjusts BrightSpring Health Services Price Target to $13 From $11.50, Maintains Buy Rating MT
BrightSpring Health Services Insider Bought Shares Worth $297,712, According to a Recent SEC Filing MT
HSBC Starts Coverage on BrightSpring Health With Buy Rating, $13 Price Target MT
Goldman Sachs Cuts Price Target on BrightSpring Health to $23 From $26, Maintains Buy Rating MT
Deutsche Bank Upgrades BrightSpring Health Services to Buy From Hold, $11.50 Price Target MT
Leerink Partners Starts BrightSpring Health Services With Outperform Rating, $15 Price Target MT
BofA Securities Starts BrightSpring Health Services With Buy Rating, $14 Price Target MT
UBS Initiates Brightspring Health Services at Buy Rating With $15 Price Target MT
Morgan Stanley Initiates Brightspring Health Services at Overweight Rating With $18 Price Target MT
Goldman Sachs Starts Coverage on BrightSpring Health With Buy Rating, $26 Price Target MT
Wells Fargo Initiates Brightspring Health Services at Overweight Rating With $15 Price Target MT
Jefferies Initiates Brightspring Health Services at Buy Rating With $18 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
11.32 USD
Average target price
16.23 USD
Spread / Average Target
+43.35%
High Price Target
23 USD
Spread / Highest target
+103.18%
Low Price Target
13 USD
Spread / Lowest Target
+14.84%

Consensus detail

Consensus revision (last 18 months)

Analysts covering BrightSpring Health Services, Inc.

Wells Fargo Securities
Deutsche Bank Securities
HSBC
Goldman Sachs
BofA Securities
Leerink Partners
UBS
Jefferies & Co.
Morgan Stanley

Ratings for BrightSpring Health Services, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BTSG Stock
  4. Consensus BrightSpring Health Services, Inc.